Related Experiment Video
Updated: Jul 12, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Knockdown of Long Noncoding RNA CCAT2 Suppresses Malignant Phenotype in Human Laryngeal Squamous Cell Carcinoma
1Department of Otolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Abstract:
This study aimed to explore the biological role and mechanism underlying the effects of colon cancer-associated transcript 2 (CCAT2), a long noncoding RNA (lncRNA) in human laryngeal squamous cell carcinoma (LSCC). CCAT2 expression levels in clinical LSCC samples and TU-212 cell line were evaluated by quantitative real-time PCR. The correlation of CCAT2 expression level with clinical-pathological characteristics of patients and their prognosis was analyzed. The functional role of CCAT2 in human LSCC was assessed by Cell Counting Kit-8, Transwell assay, flow cytometric analysis, and LSCC xenograft experiment in vivo. The expression of potential targeted proteins was detected by Western blotting and immunohistochemistry. We found that expression of CCAT2 was significantly elevated in LSCC tissues and TU-212 cells (p<0.05). Survival analysis showed that LSCC patients with high expression of CCAT2 had a shorter 5-year overall survival rate than those with low expression (p<0.05). In addition, CCAT2 silencing with short hairpin RNA significantly decreased the proliferative and invasive potential of TU-212 cells (p<0.05) and promoted their apoptosis. In Nude mice, CCAT2 knockdown suppressed the growth of tumor and decreased its volume and weight in comparison with the controls (p<0.05). In TU-212 cells, CCAT2 silencing with short hairpin RNA significantly down-regulated the expression of β-catenin and CDK8 (p<0.05). Thus, knockdown of CCAT2 suppresses proliferation and invasion of the cells and inhibits Wnt/β-catenin signaling pathway in LSCC, which indicates novel therapeutic targets and prognostic indicators in patients with LSCC.
Insights
Colon cancer-associated transcript 2 (CCAT2), a long noncoding RNA, is highly expressed in laryngeal squamous cell carcinoma (LSCC). Silencing CCAT2 inhibits LSCC cell proliferation and invasion, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Laryngeal squamous cell carcinoma (LSCC) is a significant health concern.
- The role of long noncoding RNAs (lncRNAs) in LSCC pathogenesis is increasingly recognized.
- Colon cancer-associated transcript 2 (CCAT2) is a lncRNA implicated in various cancers.
Purpose of the Study:
- To investigate the biological role and underlying mechanism of CCAT2 in human LSCC.
- To determine the correlation between CCAT2 expression and LSCC patient prognosis.
- To evaluate CCAT2 as a potential therapeutic target and prognostic biomarker for LSCC.
Main Methods:
- Quantitative real-time PCR to measure CCAT2 expression in LSCC tissues and cell lines.
- Cell Counting Kit-8, Transwell assay, and flow cytometry to assess cell proliferation, invasion, and apoptosis.
- In vivo LSCC xenograft model in nude mice to evaluate tumor growth.
- Western blotting and immunohistochemistry to detect target protein expression (β-catenin, CDK8).
Main Results:
- CCAT2 expression was significantly elevated in LSCC tissues and cells compared to normal controls.
- High CCAT2 expression correlated with poorer 5-year overall survival in LSCC patients.
- CCAT2 knockdown suppressed LSCC cell proliferation and invasion while promoting apoptosis.
- In vivo, CCAT2 knockdown inhibited tumor growth, volume, and weight.
- CCAT2 silencing down-regulated β-catenin and CDK8 expression, inhibiting the Wnt/β-catenin signaling pathway.
Conclusions:
- CCAT2 plays a crucial role in promoting LSCC progression by enhancing proliferation and invasion.
- CCAT2 acts, at least in part, by modulating the Wnt/β-catenin signaling pathway.
- CCAT2 is a potential prognostic biomarker and therapeutic target for LSCC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Non-LTR Retrotransposons
MicroRNAs
Experimental RNAi

